Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

$12M Private Funding To Help CepTor Push Myodur Program

Feb. 1, 2005

By Aaron Lorenzo

La Jolla Pharmaceutical Raising $17M Through Public Stock Sale

Jan. 31, 2005

By Aaron Lorenzo

Leavitt To Head HHS After Receiving Senate Support

Jan. 31, 2005

By Aaron Lorenzo

La Jolla Pharmaceutical Raising $17M Through Public Stock Sale

Jan. 31, 2005

By Aaron Lorenzo

Leavitt To Head HHS After Receiving Senate Support

Jan. 31, 2005

By Aaron Lorenzo

Theravance Begins Second Phase III Trial For Telavancin

Jan. 28, 2005

By Aaron Lorenzo

Theravance Begins Second Phase III Trial For Telavancin

Jan. 28, 2005

By Aaron Lorenzo

ImClone Enters Patent License Deals With Genentech, Centocor

Jan. 27, 2005

By Aaron Lorenzo

GTx's Acapodene Moves To Second Oncology Phase III

Jan. 27, 2005

By Aaron Lorenzo

GTx's Acapodene Moves To Second Oncology Phase III

Jan. 27, 2005

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...